ESET researchers reveal how malware operators collaborate with covert North Korean IT workers, posing a threat to both headhunters and job seekers.

GSK has reported much-needed progress with two of its cancer therapies, with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for myelofibrosis ...

For basic access, please submit an OnBase Application Access Request. If you are a power user, you may need to request the Unity Client or Outlook Integration Plug-in for your workstation. Submit a ...